Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot International flag

This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot2: STU1 Ballot 2) based on FHIR (HL7® FHIR® Standard) v6.0.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions

Example EvidenceVariable: CTIS2024-516402-32-00 Secondary Outcome 8

Page standards status: Informative

Generated Narrative: EvidenceVariable 346495

version: 2; Last updated: 2025-03-05 19:33:28+0000

url: EvidenceVariable CTIS2024-516402-32-00 Secondary Outcome 8

identifier: FEvIR Object Identifier/https://fevir.net/FOI/346495, FEvIR Linking Identifier/CTIS2024-516402-32-00 Secondary Outcome 8, CTIS endPoint id/441516, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.11

version: 1.0.0-ballot2

name: CTIS2024_516402_32_00_Secondary_Outcome_8

title: CTIS2024-516402-32-00 Secondary Outcome 8

status: Active

date: 2025-03-28 17:11:38+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description:

Costs relating to renal replacement therapy (or lack of), Eculizumab and other antihypertensive treatments, hospitalizations

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

author: Brian S. Alper, MD, MSPH: